{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:03:10Z","timestamp":1791187390922,"version":"4.1.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.vaccine.2009.06.032","type":"journal-article","created":{"date-parts":[[2009,6,25]],"date-time":"2009-06-25T06:22:20Z","timestamp":1245910940000},"page":"5043-5053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Influenza control in the 21st century: Optimizing protection of older adults"],"prefix":"10.1016","volume":"27","author":[{"given":"Arnold S.","family":"Monto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Ansaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Aspinall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet E.","family":"McElhaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Monta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin L.","family":"Nichol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Puig-Barber\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2009.06.032_bib1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/ije\/22.2.334","article-title":"Impact of influenza on mortality in relation to age and underlying disease, 1967\u20131989","volume":"22","author":"Sprenger","year":"1993","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.06.032_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.vaccine.2009.06.032_bib3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States","volume":"292","author":"Thompson","year":"2004","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2009.06.032_bib4","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.vaccine.2005.04.019","article-title":"The unmet need in the elderly: designing new influenza vaccines for older adults","volume":"23","author":"McElhaney","year":"2005","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2009.06.032_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1473-3099(02)00437-1","article-title":"Ageing and infection","volume":"2","author":"Gavazzi","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"33","key":"10.1016\/j.vaccine.2009.06.032_bib6","first-page":"279","article-title":"Influenza vaccines","volume":"80","author":"World Health Organization (WHO)","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2009.06.032_bib7","first-page":"1","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","volume":"57","author":"Centers for Disease Control and Prevention (CDC)","year":"2008","journal-title":"MMWR"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.032_bib8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2165\/00003495-199754060-00004","article-title":"Influenza vaccines. A reappraisal of their use","volume":"54","author":"Palache","year":"1997","journal-title":"Drugs"},{"issue":"16","key":"10.1016\/j.vaccine.2009.06.032_bib9","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0264-410X(03)00070-7","article-title":"The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines","volume":"21","author":"Nichol","year":"2003","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.06.032_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.virusres.2004.02.025","article-title":"Immunogenicity and protective efficacy of influenza vaccination","volume":"103","author":"Hannoun","year":"2004","journal-title":"Virus Res"},{"issue":"44\u201346","key":"10.1016\/j.vaccine.2009.06.032_bib11","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1016\/j.vaccine.2006.05.063","article-title":"Real-time monitoring of the influenza vaccine field effectiveness","volume":"24","author":"Legrand","year":"2006","journal-title":"Vaccine"},{"issue":"39\u201340","key":"10.1016\/j.vaccine.2009.06.032_bib12","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1016\/j.vaccine.2007.07.027","article-title":"Influenza vaccine: the challenge of antigenic drift","volume":"25","author":"Carrat","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.06.032_bib13","unstructured":"World Health Organization (WHO). Fact sheet no. 211. March 2003. [Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs211\/en. Accessed November 18, 2008]."},{"key":"10.1016\/j.vaccine.2009.06.032_bib14","series-title":"Principles and practice of infectious diseases","first-page":"1306","article-title":"Influenza virus","author":"Betts","year":"1990"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.032_bib15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1056\/NEJMp038238","article-title":"Influenza vaccine\u2014outmaneuvering antigenic shift and drift","volume":"350","author":"Treanor","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.032_bib16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1086\/381165","article-title":"Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons","volume":"189","author":"Hak","year":"2004","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.032_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/occmed\/kqg087","article-title":"Factors influencing uptake of influenza vaccination among hospital-based health care workers","volume":"54","author":"Qureshi","year":"2004","journal-title":"Occup Med (Lond)"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.032_bib18","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1086\/313792","article-title":"Epidemiology and unique aspects of aging and infectious diseases","volume":"30","author":"Yoshikawa","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.032_bib19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1017\/S0950268800050032","article-title":"Influenza deaths in Leicestershire during the 1989\u20131990 epidemic: implications for prevention","volume":"108","author":"Nguyen-Van-Tam","year":"1992","journal-title":"Epidemiol Infect"},{"issue":"27","key":"10.1016\/j.vaccine.2009.06.032_bib20","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1016\/j.vaccine.2007.03.046","article-title":"The annual impact of seasonal influenza in the US: measuring disease burden and costs","volume":"25","author":"Molinari","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.06.032_bib21","unstructured":"Hospital Episode Statistics. Primary diagnosis: summary 2005\u20132006. [Available at: http:\/\/www.hesonline.nhs.uk\/Ease\/servlet\/ContentServer?siteID=1937&categoryID=202. Accessed November 18, 2007]."},{"issue":"7","key":"10.1016\/j.vaccine.2009.06.032_bib22","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.vaccine.2004.12.033","article-title":"The cost-effectiveness of influenza vaccination of healthy adults 50\u201364 years of age","volume":"24","author":"Turner","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.032_bib23","first-page":"231","article-title":"Influenza and adult hospital admissions for respiratory conditions in England 1989\u20132001","volume":"6","author":"Fleming","year":"2003","journal-title":"Commun Dis Public Health"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2009.06.032_bib24","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1086\/507548","article-title":"Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts and nursing home residents","volume":"194","author":"Whitley","year":"2006","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.032_bib25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archinte.158.6.645","article-title":"A study of the impact of influenza on the functional status of frail older people","volume":"158","author":"Barker","year":"1998","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.032_bib26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1086\/426082","article-title":"A new paradigm for clinical investigation of infectious syndromes in older adults: assessment of functional status as a risk factor and outcome measure","volume":"40","author":"High","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2009.06.032_bib27","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jama.1997.03540330050034","article-title":"Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older people become severely disabled","volume":"277","author":"Ferrucci","year":"1997","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.vaccine.2009.06.032_bib28","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.06.032_bib29","unstructured":"Elixhauser A, Yu K, Steiner C, Bierman AS. Hospitalization in the United States, 1997. Rockville (MD): Agency for healthcare research and quality; 2000. HCUP Fact Book No. 1; AHRQ. Publication No. 00-0031. ISBN 1-58763-005-2."},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.032_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1532-5415.2003.51152.x","article-title":"Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age","volume":"51","author":"Covinsky","year":"2003","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"10.1016\/j.vaccine.2009.06.032_bib31","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/eurheartj\/ehm035","article-title":"Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects","volume":"28","author":"Madjid","year":"2007","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.vaccine.2009.06.032_bib32","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJMoa025028","article-title":"Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly","volume":"348","author":"Nichol","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2009.06.032_bib33","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwh227","article-title":"Influenza and the winter increase in mortality in the United States, 1959\u20131999","volume":"160","author":"Reichert","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.06.032_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1017\/S0950268804003231","article-title":"Influenza and its relationship to circulatory disorders","volume":"133","author":"Fleming","year":"2005","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2009.06.032_bib35","series-title":"Epidemiology and prevention of vaccine-preventable diseases","first-page":"235","article-title":"Influenza","author":"Centers for Disease Control and Prevention (CDC)","year":"2008"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.032_bib36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1057\/palgrave.jphp.3200008","article-title":"Preparing for pandemic vaccination: an international policy agenda for vaccine development","volume":"26","author":"Fedson","year":"2005","journal-title":"J Public Health Policy"},{"issue":"16","key":"10.1016\/j.vaccine.2009.06.032_bib37","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0264-410X(03)00072-0","article-title":"Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries","volume":"21","author":"Van Essen","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.06.032_bib38","unstructured":"Centers for Disease Control and Prevention (CDC). Role of laboratory diagnosis of influenza. [Last updated 2006. Available at: http:\/\/www.cdc.gov\/flu\/professionals\/diagnosis\/labrole.htm. Accessed November 18, 2008]."},{"issue":"2","key":"10.1016\/j.vaccine.2009.06.032_bib39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ije\/dyi274","article-title":"Evidence of bias in estimates of influenza vaccine effectiveness in seniors","volume":"35","author":"Jackson","year":"2006","journal-title":"Int J Epidemiol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.06.032_bib40","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S1473-3099(07)70236-0","article-title":"Mortality benefits of influenza vaccination in elderly people: an ongoing controversy","volume":"7","author":"Simonsen","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2009.06.032_bib41","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0264-410X(02)00041-5","article-title":"A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community","volume":"20","author":"Vu","year":"2002","journal-title":"Vaccine"},{"issue":"9492","key":"10.1016\/j.vaccine.2009.06.032_bib42","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(05)67339-4","article-title":"Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review","volume":"366","author":"Jefferson","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.032_bib43","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/341403","article-title":"Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations","volume":"35","author":"Hak","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2009.06.032_bib44","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/S0264-410X(02)00154-8","article-title":"Economic evaluation of strategies for the control and management of influenza in Europe","volume":"20","author":"Scuffham","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.032_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.amepre.2006.03.008","article-title":"Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older","volume":"31","author":"Maciosek","year":"2006","journal-title":"Am J Prev Med"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.032_bib46","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ypmed.2005.12.004","article-title":"Could a federal program to promote influenza vaccination among elders be cost-effective?","volume":"42","author":"Patel","year":"2006","journal-title":"Prev Med"},{"issue":"11","key":"10.1016\/j.vaccine.2009.06.032_bib47","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.4049\/jimmunol.168.11.5893","article-title":"Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines","volume":"168","author":"Saurwein-Teissl","year":"2002","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.032_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2567.2004.02006.x","article-title":"Age-related loss of na\u00efve T cells and dysregulation of T-cell\/B-cell interactions in human lymph nodes","volume":"114","author":"Lazuardi","year":"2005","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.032_bib49","first-page":"2","article-title":"Aging, nutrition and immune function","volume":"8","author":"Ahluwalia","year":"2004","journal-title":"J Nutr Health Aging"},{"issue":"8","key":"10.1016\/j.vaccine.2009.06.032_bib50","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nm0898-870b","article-title":"No immunity for the elderly","volume":"4","author":"Grubeck-Loebenstein","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2009.06.032_bib51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.me.15.020164.000323","article-title":"Embryological development of the immune mechanism","volume":"15","author":"Miller","year":"1964","journal-title":"Annu Rev Med"},{"issue":"December 11","key":"10.1016\/j.vaccine.2009.06.032_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-4933-4-9","article-title":"Challenges for vaccination in the elderly","volume":"4","author":"Aspinall","year":"2007","journal-title":"Immun and Ageing"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.032_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/smim.1998.0148","article-title":"The human thymic microenvironment: new approaches to functional analysis","volume":"11","author":"Ritter","year":"1999","journal-title":"Semin Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.032_bib54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0167-5699(96)80543-3","article-title":"Thymic involution with ageing: obsolescence or good housekeeping?","volume":"17","author":"George","year":"1996","journal-title":"Immunol Today"},{"issue":"6712","key":"10.1016\/j.vaccine.2009.06.032_bib55","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/25374","article-title":"Changes in thymic function with age and during the treatment of HIV infection","volume":"396","author":"Douek","year":"1998","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.032_bib56","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.166.3.1524","article-title":"Il-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice","volume":"166","author":"Andrew","year":"2001","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.06.032_bib57","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1002\/1521-4141(2002010)32:10<2827::AID-IMMU2827>3.0.CO;2-X","article-title":"Molecular quantitation of thymic output in mice and the effect of IL-7","volume":"32","author":"Pido-Lopez","year":"2002","journal-title":"Eur J Immunol"},{"issue":"September 15 (6)","key":"10.1016\/j.vaccine.2009.06.032_bib58","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.4049\/jimmunol.175.6.4112","article-title":"An IL-7 fusion protein that shows increased thymopoietic ability","volume":"175","author":"Henson","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.032_bib59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/rej.2006.9098","article-title":"Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination","volume":"10","author":"Aspinall","year":"2007","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.vaccine.2009.06.032_bib60","unstructured":"World Health Organization (WHO). Recommendations for influenza vaccine composition. [Available at: http:\/\/www.who.int\/csr\/disease\/influenza\/vaccinerecommendations1\/en\/index.html. Accessed November 18, 2008]."},{"issue":"10","key":"10.1016\/j.vaccine.2009.06.032_bib61","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1073\/pnas.87.10.3884","article-title":"Evolutionary changes in influenza B are not primarily governed by antibody selection","volume":"87","author":"Air","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.032_bib62","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1044-5773(05)80013-7","article-title":"The molecular epidemiology of influenza viruses","volume":"6","author":"Cox","year":"1995","journal-title":"Sem Virol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.06.032_bib63","doi-asserted-by":"crossref","first-page":"7343","DOI":"10.1128\/JVI.73.9.7343-7348.1999","article-title":"insertion-deletion are strategies for the evolution of influenza B viruses in nature","volume":"73","author":"McCullers","year":"1999","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.032_bib64","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0042-6822(88)90238-3","article-title":"Influenza B virus evolution: co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses","volume":"163","author":"Yamashita","year":"1988","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.vaccine.2009.06.032_bib65","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s007050050399","article-title":"Evolutionary characteristics of influenza B virus since its first isolation in 1940: dynamic circulation of deletion and insertion mechanism","volume":"143","author":"Nerome","year":"1998","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.032_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.2002.1719","article-title":"Reappearance and global spread of variants of influenza B\/Victoria\/2\/87 lineage viruses in the 2000\u20132001 and 2001\u20132002 seasons","volume":"303","author":"Shaw","year":"2002","journal-title":"Virology"},{"issue":"5682","key":"10.1016\/j.vaccine.2009.06.032_bib67","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.vaccine.2009.06.032_bib68","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.vaccine.2008.01.019","article-title":"Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and hemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses","volume":"26","author":"Ansaldi","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.032_bib69","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<94::AID-JMV15>3.0.CO;2-C","article-title":"Mismatch between the 1997\/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly","volume":"61","author":"de Jong","year":"2000","journal-title":"J Med Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2009.06.032_bib70","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1016\/j.vaccine.2006.01.015","article-title":"An MF59-adjuvanted inactivated influenza vaccine containing A\/Panama\/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A\/Fujian\/2002 than a subunit and a split influenza vaccine","volume":"24","author":"Del Giudice","year":"2006","journal-title":"Vaccine"},{"issue":"33\u201334","key":"10.1016\/j.vaccine.2009.06.032_bib71","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1016\/j.vaccine.2006.05.009","article-title":"Cross-reactivity of influenza A (H3N2) hemagglutination-inhibition antibodies induced by an inactivated influenza vaccine","volume":"24","author":"Kojimahara","year":"2006","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.032_bib72","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1086\/323085","article-title":"Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans","volume":"184","author":"Nordin","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.06.032_bib73","series-title":"Encyclopedia of life sciences","article-title":"New generation vaccine adjuvants","author":"Hagan","year":"2007"},{"key":"10.1016\/j.vaccine.2009.06.032_bib74","series-title":"New generation vaccines","first-page":"225","article-title":"MF59 adjuvant emulsion","author":"Podda","year":"2004"},{"issue":"5","key":"10.1016\/j.vaccine.2009.06.032_bib75","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1586\/14760584.6.5.699","article-title":"MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infections","volume":"6","author":"O\u2019Hagan","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2009.06.032_bib76","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1016\/S0264-410X(99)00138-3","article-title":"Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly","volume":"17","author":"De Donato","year":"1999","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2009.06.032_bib77","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1016\/S0264-410X(01)00060-3","article-title":"Comparison of three different influenza vaccines in institutionalised elderly","volume":"19","author":"Baldo","year":"2001","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2009.06.032_bib78","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0264-410X(02)00401-2","article-title":"Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects","volume":"21","author":"Squarcione","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.06.032_bib79","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-4933-5-2","article-title":"Safety and immunogenicity of an MF59\u2122adjuvanted influenza subunit vaccine in elderly Chinese subjects","volume":"5","author":"Li","year":"2008","journal-title":"Immun Ageing"},{"issue":"5","key":"10.1016\/j.vaccine.2009.06.032_bib80","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1586\/14760584.6.5.659","article-title":"MF59-adjuvanted subunit influenza vaccine: an improved interpandemic influenza vaccine for vulnerable populations","volume":"6","author":"Puig-Barber\u00e0","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2009.06.032_bib81","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0264-410X(00)00499-0","article-title":"The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine","volume":"19","author":"Podda","year":"2001","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.032_bib82","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000069172","article-title":"A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis","volume":"49","author":"Banzhoff","year":"2003","journal-title":"Gerontology"},{"issue":"11","key":"10.1016\/j.vaccine.2009.06.032_bib83","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10654-006-9071-4","article-title":"Response to influenza vaccine in people with non-protective HI antibody titers","volume":"21","author":"Baldo","year":"2006","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.06.032_bib84","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0264-410X(98)00185-6","article-title":"Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons","volume":"17","author":"Minutello","year":"1999","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.032_bib85","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1017\/S0950268805003936","article-title":"Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy","volume":"133","author":"Iob","year":"2005","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.032_bib86","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.vaccine.2004.07.017","article-title":"Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age","volume":"23","author":"Puig-Barber\u00e0","year":"2004","journal-title":"Vaccine"},{"issue":"42","key":"10.1016\/j.vaccine.2009.06.032_bib87","doi-asserted-by":"crossref","first-page":"7313","DOI":"10.1016\/j.vaccine.2007.08.039","article-title":"Effectiveness of the MF59\u2122-adjuvanted subunit influenza vaccine in preventing hospitalizations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly","volume":"25","author":"Puig-Barber\u00e0","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.06.032_bib88","unstructured":"Leroux-Roels I, Clement F, Leroux-Roels G, Dram\u00e9 M, Moris P, Devaster JM, et al. Adjuvanted influenza vaccines improve anti-influenza cellular mediated immunity impaired in elderly. Poster presented at: Influenza Vaccines for the World, October 18\u201320, 2006; Vienna, Austria."},{"key":"10.1016\/j.vaccine.2009.06.032_bib89","unstructured":"Leroux-Roels I, Oostvogels L, Hons E, Leroux-Roels G, Devaster J-M, Ripley Ballou W. Reactogenicity and safety of adjuvanted influenza vaccines administered in elderly. Poster presented at: Influenza Vaccines for the World, October 18\u201320, 2006; Vienna, Austria."},{"key":"10.1016\/j.vaccine.2009.06.032_bib90","unstructured":"Baras B, Jacob V, M\u00e9hauden S, Hanon E, Wettendorff M. Cross-protection in ferrets after vaccination with adjuvanted influenza split vaccine. Poster presented at: Influenza Vaccines for the World, 18\u201320 October, 2006; Vienna, Austria."},{"issue":"8","key":"10.1016\/j.vaccine.2009.06.032_bib91","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-117-8-625","article-title":"Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly","volume":"117","author":"Treanor","year":"1992","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.032_bib92","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1386-6532(01)00246-3","article-title":"The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly","volume":"24","author":"Stepanova","year":"2002","journal-title":"J Clin Virol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2009.06.032_bib93","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.vaccine.2005.04.020","article-title":"Clinical experience with inactivated, virosomal influenza vaccine","volume":"23","author":"de Bruijn","year":"2005","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2009.06.032_bib94","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.vaccine.2005.04.026","article-title":"The virosome concept for influenza vaccines","volume":"23","author":"Huckriede","year":"2005","journal-title":"Vaccine"},{"issue":"44\u201346","key":"10.1016\/j.vaccine.2009.06.032_bib95","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1016\/j.vaccine.2006.05.035","article-title":"The virosomal influenza vaccine Invivac: immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad\u00ae) in elderly subjects","volume":"24","author":"de Bruijn","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.032_bib96","first-page":"38","article-title":"Immunogenicity and safety of three commercial influenza vaccines in institutionalized elderly","volume":"13","author":"Pregliasco","year":"2001","journal-title":"Aging (Milano)"},{"issue":"10","key":"10.1016\/j.vaccine.2009.06.032_bib97","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archinte.166.10.1121","article-title":"Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons","volume":"166","author":"Keitel","year":"2006","journal-title":"Arch Intern Med"},{"issue":"44","key":"10.1016\/j.vaccine.2009.06.032_bib98","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1016\/j.vaccine.2007.08.042","article-title":"Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects","volume":"25","author":"Couch","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2009.06.032_bib99","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.vaccine.2004.06.036","article-title":"Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch","volume":"23","author":"Frech","year":"2005","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2009.06.032_bib100","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.vaccine.2009.06.032_bib101","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1056\/NEJMoa061850","article-title":"Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines","volume":"355","author":"Ohmit","year":"2006","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.vaccine.2009.06.032_bib102","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0264-410X(99)00508-3","article-title":"Approaches to improved influenza vaccination","volume":"18","author":"Betts","year":"2000","journal-title":"Vaccine"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2009.06.032_bib103","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0264-410X(02)00748-X","article-title":"Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study","volume":"21","author":"Gorse","year":"2003","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2009.06.032_bib104","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1016\/j.vaccine.2005.08.012","article-title":"Epidermal DNA vaccine for influenza is immunogenic in humans","volume":"24","author":"Drape","year":"2006","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2009.06.032_bib105","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1086\/503050","article-title":"Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza virus hemagglutinin vaccine in elderly adults","volume":"193","author":"Treanor","year":"2006","journal-title":"J Infect Dis"},{"issue":"21","key":"10.1016\/j.vaccine.2009.06.032_bib106","doi-asserted-by":"crossref","first-page":"11371","DOI":"10.1073\/pnas.93.21.11371","article-title":"Alphavirus-based expression vectors: strategies and applications","volume":"93","author":"Frolov","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.032_bib107","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.vaccine.2006.08.026","article-title":"Antibody responses after dose-sparing intradermal influenza vaccination","volume":"25","author":"Auewarakul","year":"2007","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2009.06.032_bib108","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa043540","article-title":"Dose sparing with intradermal injection of influenza vaccine","volume":"351","author":"Kenney","year":"2004","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.032_bib109","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1542\/peds.2006-3176","article-title":"Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children","volume":"119","author":"Chiu","year":"2007","journal-title":"Pediatrics"},{"issue":"22","key":"10.1016\/j.vaccine.2009.06.032_bib110","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa043555","article-title":"Serum antibody responses after intradermal vaccination against influenza","volume":"351","author":"Belshe","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2009.06.032_bib111","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/590434","article-title":"Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial","volume":"198","author":"Holland","year":"2008","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.032_bib112","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3201\/eid1204.051020","article-title":"Prospects for universal influenza virus vaccine","volume":"12","author":"Gerhard","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.032_bib113","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/infdis\/140.6.844","article-title":"Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection","volume":"140","author":"Beutner","year":"1979","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2009.06.032_bib114","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1128\/JVI.79.12.7380-7388.2005","article-title":"Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor","volume":"79","author":"Bianchi","year":"2005","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.032_bib115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00063030-200620060-00003","article-title":"Evolving strategies for the prevention of influenza infection: potential for multistrain targeting","volume":"20","author":"Livingston","year":"2006","journal-title":"BioDrugs"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2009.06.032_bib116","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0531-5565(01)00210-8","article-title":"Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly","volume":"37","author":"Murasko","year":"2002","journal-title":"Exp Gerontol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.06.032_bib117","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.4049\/jimmunol.176.10.6333","article-title":"T cell responses are better correlates of vaccine protection in the elderly","volume":"176","author":"McElhaney","year":"2006","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09008810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09008810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:16:10Z","timestamp":1759400170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09008810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":117,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0264410X09008810"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.06.032","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influenza control in the 21st century: Optimizing protection of older adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}